Teleflex
TFX
Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them
Managers holding
1
In their latest 13F (Q3 2026)
See who
Value held
$179m
Combined value at quarter end
Last quarter
0 bought
1 sold or trimmed
Price at Q2 ’26 end
$126.76
+6.0% in the quarter
Share price change by quarter
+8.0%Q1 ’22
-30.6%Q2 ’22
-18.0%Q3 ’22
+23.8%Q4 ’22
-0.3%Q4 ’25
-2.0%Q1 ’26
+6.0%Q2 ’26
Managers holding it, by quarter
0Q4 ’23
0Q1 ’24
0Q2 ’24
0Q3 ’24
0Q4 ’24
0Q1 ’25
0Q2 ’25
1Q3 ’25
1Q4 ’25
1Q1 ’26
1Q2 ’26
0Q3 ’26
Who holds it
| Baupost Group | 3.3%$179m | Trimmed -12% |
About the company
- Sector
- Health care · Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Financial year ends
- 31 December
- Shares outstanding
- 42m at 4 Aug 2026
- SEC filings
- Annual reports and other filings on EDGAR
Revenue and profit
$1.7bn2013
$1.8bn2015
$2.1bn2017
$2.6bn2019
$2.8bn2021
$1.7bn2023
$2.0bn2025
| Year | Revenue | Net income |
|---|---|---|
| 2025 | $2.0bn | −$906m |
| 2024 | $1.7bn | $70.2m |
| 2023 | $1.7bn | $358m |
| 2022 | $2.8bn | $363m |
| 2021 | $2.8bn | $485m |
| 2020 | $2.5bn | $335m |
| 2019 | $2.6bn | $461m |
| 2018 | $2.4bn | $201m |
| 2017 | $2.1bn | $153m |
| 2016 | $1.9bn | $237m |
| 2015 | $1.8bn | $245m |
| 2014 | $1.8bn | $188m |
| 2013 | $1.7bn | $151m |